BCL2L1 and Hyperglycemia: In this model, over a 7 day period Ins-cMycERTAM Bcl-xL islet expansion is accompanied by reduced insulin expression in β cells with accompanying hyperglycemia (Pelengaris et al., 2002) (Figure 6D).